Skip to content

Savara SVRA Income Tax

Income Tax at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
$0
Innoviva, Inc. logo
Innoviva, Inc.INVA
$47.97M+500%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$1.54M-175%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
$10.73M+149%
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$20K-73.0%
TRV
Trevi Therapeutics, Inc.TRVI
-$20K-81.8%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Savara’s 10-K, filed March 12, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.